Could this Healthcare Stock really climb 73.73% by 2024?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Secret Gold Back currency RUINING Biden's plans for a digital dollar?]( [There is a secret currency that’s beginning to spread across America. Click here now for details.]( --------------------------------------------------------------- September 1, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [VC issues new kind of AI warning]( to Elon Musk, “we need to be very careful about artificial intelligence.” And yet following the money reveals a completely different story. It’s why venture capitalist Luke Lango just issued a new kind of AI warning. [Click here because he says you only have ONE shot to act.]( --------------------------------------------------------------- [AeroVironment]( Symbol: [AVAV]( Recent Price: $97.03 Average Analyst Price Target: $113.75 (17.23%) Market Cap: $2.54B Last Year's EPS: -$0.01 Consensus EPS Forecast: $1.02 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: Brian Gesuale, analyst at Raymond James, reiterates coverage on [AeroVironment (AVAV)]( in the Industrials sector with a Buy rating and a price target of $130 (1 month ago). [TipRanks.com]( also reports that [AeroVironment]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $113.75 . The target pricing ranges from a high forecast of $130.00 down to a low forecast of $95.00. [AeroVironment (AVAV)](’s last closing price was $97.03 which would put the average price target at 17.23% upside. Here are 3rd party ratings for [AVAV](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 24% (58 out of 246) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [5G Stock CRUSHES Earnings!!]( Street is loading up on shares of one 5G SuperStock (with more than $2 billion invested!). Why? Because the stock brings in more cash than IBM, Facebook and even Google! Yet it trades for just $3. [Get the scoop on the 5G SuperStock right here.]( --------------------------------------------------------------- [Brady]( Symbol: [BRC]( Recent Price: $50.44 Average Analyst Price Target: $47.00 (-6.82%) Market Cap: $2.50B Last Year's EPS: $0.81 Consensus EPS Forecast: $0.92 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: George Staphos, analyst at Bank of America Securities, reiterates coverage on [Brady (BRC)]( in the Industrials sector with a Sell rating and a price target of $47 (1 month ago). [TipRanks.com]( also reports that [Brady]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Sell rating with an average price target is $47.00 . The target pricing ranges from a high forecast of $47.00 down to a low forecast of $47.00. [Brady (BRC)](’s last closing price was $50.44 which would put the average price target at -6.82% upside. Here are 3rd party ratings for [BRC](: - TipRanks.com: Moderate Sell - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 34% (162 out of 246) [Click for chart >>]( -------------------------------------------------------------------------- [Avid Bioservices]( Symbol: [CDMO]( Recent Price: $11.80 Average Analyst Price Target: $20.50 (73.73%) Market Cap: $752.75M Last Year's EPS: $0.01 Consensus EPS Forecast: $0.02 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: Matt Hewitt, analyst at Craig-Hallum, reiterates coverage on [Avid Bioservices (CDMO)]( in the Healthcare sector with a Buy rating (3 weeks ago). [TipRanks.com]( also reports that [Avid Bioservices]( currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.50 . The target pricing ranges from a high forecast of $24.00 down to a low forecast of $17.00. [Avid Bioservices (CDMO)](’s last closing price was $11.80 which would put the average price target at 73.73% upside. Here are 3rd party ratings for [CDMO](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 39% (95 out of 246) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Look Beyond Wind and Solar: Unlock "Infinite Energy"]( you think traditional sources like oil, gas, wind and solar are the only ways to generate electricity — guess again! With groundbreaking software turning a tiny Silicon Valley company into a power player in energy production, we're entering uncharted territory. Don’t miss out on uncovering this potentially game-changing opportunity ... [watch this free video now to learn how it all works and which stock is set to fly any minute.]( --------------------------------------------------------------- [America's Car-Mart]( Symbol: [CRMT]( Recent Price: $111.31 Average Analyst Price Target: $135.00 (21.28%) Market Cap: $729.34M Last Year's EPS: $0.23 Consensus EPS Forecast: $1.13 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: Vincent Caintic, analyst at Stephens, reiterates coverage on [America's Car-Mart (CRMT)]( in the Consumer Cyclical sector with a Buy rating and a price target of $135 (1 month ago). [TipRanks.com]( also reports that [America's Car-Mart]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $135.00 . The target pricing ranges from a high forecast of $135.00 down to a low forecast of $135.00. [America's Car-Mart (CRMT)](’s last closing price was $111.31 which would put the average price target at 21.28% upside. Here are 3rd party ratings for [CRMT](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 20% (49 out of 246) [Click for chart >>]( -------------------------------------------------------------------------- [Grindrod Shipping Holdings]( Symbol: [GRIN]( Recent Price: $8.04 Average Analyst Price Target: $12.50 (55.47%) Market Cap: $156.17M Last Year's EPS: $1.14 Consensus EPS Forecast: -$0.63 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: Poe Fratt, analyst at Alliance Global Partners, reiterates coverage on [Grindrod Shipping Holdings (GRIN)]( in the Industrials sector with a Buy rating and a price target of $12.5 (1 month ago). [TipRanks.com]( also reports that [Grindrod Shipping Holdings]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.50 . The target pricing ranges from a high forecast of $12.50 down to a low forecast of $12.50. [Grindrod Shipping Holdings (GRIN)](’s last closing price was $8.04 which would put the average price target at 55.47% upside. Here are 3rd party ratings for [GRIN](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Tech Stock Paying 10% (for now)]( reader, I'm about to show you a tech stock that's breaking out to new highs as you're reading this. It pays a 10% dividend… And is riding the wave of the tech surge we've seen in 2023. No, it's not an AI stock or semiconductor. Actually it's a high-yielder that would've got you into companies like Pinterest and Zoom. If you take this stock and plug it into my most popular income plan...it could set you up to pay your bills for life. [Click here to see this 10% yielder.]( --------------------------------------------------------------- [Zscaler]( Symbol: [ZS]( Recent Price: $156.05 Average Analyst Price Target: $171.96 (10.20%) Market Cap: $21.49B Last Year's EPS: $0.37 Consensus EPS Forecast: $0.42 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: Shrenik Kothari, analyst at Robert W. Baird, reiterates coverage on [Zscaler (ZS)]( in the Technology sector with a Buy rating and a price target of $185 (4 days ago). [TipRanks.com]( also reports that [Zscaler]( currently has 27 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $171.96 . The target pricing ranges from a high forecast of $225.00 down to a low forecast of $120.00. [Zscaler (ZS)](’s last closing price was $156.05 which would put the average price target at 10.20% upside. Here are 3rd party ratings for [ZS](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 42% (103 out of 246) [Click for chart >>]( -------------------------------------------------------------------------- [Ascendis Pharma]( Symbol: [ASND]( Recent Price: $98.02 Average Analyst Price Target: $138.88 (41.69%) Market Cap: $5.43B Last Year's EPS: -$3.7 Consensus EPS Forecast: -$2.66 Expected Earnings Date: Sept 05 2023 Recent Analyst Action: Vikram Purohit, analyst at Morgan Stanley, reiterates coverage on [Ascendis Pharma (ASND)]( in the Healthcare sector with a Hold rating and a price target of $109 (1 week ago). [TipRanks.com]( also reports that [Ascendis Pharma]( currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $138.88 . The target pricing ranges from a high forecast of $187.00 down to a low forecast of $89.00. [Ascendis Pharma (ASND)](’s last closing price was $98.02 which would put the average price target at 41.69% upside. Here are 3rd party ratings for [ASND](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 39% (95 out of 246) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Beauty of "Amazon's Secret Program" 96%OFF - LABOR DAY SALE]( to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon Secret Royalty Program…” The "Amazon secret royalty program." And the best part is, there are: - NO age or income requirements… (It’s available to anyone 18+ or older) - NO employment requirements… (You can be working part-time, full-time, or even be retired) - You NEVER have to shop or sell a single product on Amazon… (It only takes 5 minutes to set up!) - And now it’s easier than ever to start taking advantage of “Amazon’s Secret Royalty Program…” See how to collect the next payout before the September 10th deadline… [Watch the short video now.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. [If you are not a human, click here.]( MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software